gip/glp 1-agonist tirzepatide Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health GIPR/GLP-1R dual agonist therapies for

Description

GIP reduces apoptosis in mouse pancreatic -cells by enhancing the expression of the antiapoptotic gene B-cell/CLL lymphoma 2 (Bcl-2) through the PKA-mediated formation of a phosphorylated cAMP response element-binding protein (CREB) and target of rapamycin complex 2 (TORC2) complex

Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure - Proposal of a Novel Mechanism of Action

Peng Luo, Email: [email protected]

For patients with diabetes, there have been studies showing that medical providers are less likely to prescribe certain medications to commercially insured patients who are Black, than they are to those who are white, says Rocio Pereira, MD, chief of Endocrinology at Denver Health